Mayo Clinic Care Network Content
Articles

Serotonin and norepinephrine reuptake inhibitors (SNRIs)

SNRIs approved to treat depression

The Food and Drug Administration (FDA) has approved these SNRIs to treat depression:

  • Desvenlafaxine (Pristiq)
  • Duloxetine (Cymbalta) — also approved to treat anxiety and certain types of chronic pain
  • Levomilnacipran (Fetzima)
  • Venlafaxine (Effexor XR) — also approved to treat certain anxiety disorders and panic disorder